Literature DB >> 32005435

Lung Cancer Staging.

Leila Kutob1, Frank Schneider2.   

Abstract

Lung cancer staging is a foundation of patient care, informing management decisions and prognosis. This comprehensive overview of the current 8th edition American Joint Committee on Cancer Cancer Staging Manual addresses common difficulties in staging, such as measuring the invasive component of adenocarcinomas and staging multiple lung nodules.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AJCC; Lung cancer; Multiple nodules; Staging; Subtyping; TNM

Mesh:

Year:  2019        PMID: 32005435     DOI: 10.1016/j.path.2019.10.003

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  11 in total

Review 1.  Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

Authors:  Zhe Zhang; Sen Yang; Yanfang Ma; Hanqiong Zhou; Xuan Wu; Jing Han; Jiabao Hou; Lidan Hao; Jonathan D Spicer; Young Wha Koh; Mariano Provencio; Noemi Reguart; Tetsuya Mitsudomi; Qiming Wang
Journal:  Transl Lung Cancer Res       Date:  2021-06

2.  Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer.

Authors:  Xu Cheng; Tianyu Ma; Ling Yi; Chongyu Su; Xiaojue Wang; Tao Wen; Bing Wang; Yuxuan Wang; Hongtao Zhang; Zhidong Liu
Journal:  Ann Transl Med       Date:  2021-03

Review 3.  Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia.

Authors:  Kevin D Seely; Amanda D Morgan; Lauren D Hagenstein; Garrett M Florey; James M Small
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

4.  Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.

Authors:  Ping Chen; Wei Lu; Tingting Chen
Journal:  J Clin Lab Anal       Date:  2021-09-23       Impact factor: 2.352

5.  Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer.

Authors:  Liqun Shang; Wei Zhang; Hua Wu; Runmiao Wu; Ruilin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-14       Impact factor: 2.629

Review 6.  Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update.

Authors:  Yi-Hsing Chen; Ue-Cheung Ho; Lu-Ting Kuo
Journal:  Cancers (Basel)       Date:  2022-03-06       Impact factor: 6.639

7.  Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis.

Authors:  Lan Xiong; Youfan Jiang; Tianyang Hu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

8.  Evaluation of the association between vitamin D and lung cancer skin metastasis: A protocol for systematic review.

Authors:  Dan Zhao; Tao Wang; Yu-Feng Li; Jian-Wei Huang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

9.  The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese.

Authors:  Xueling Lan; Ying Li; Yefeng Wu; Xia Li; Lan Xu
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

10.  [CCL18 Promotes the Invasion of Lung Adenocarcinoma through ANXA2].

Authors:  Zikun Deng; Qinpei Xiao; Yuanhang Zheng; Ruijun Feng; Zhimei Sheng; Baogang Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.